228 related articles for article (PubMed ID: 17041006)
1. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
Kirkwood KL; Li F; Rogers JE; Otremba J; Coatney DD; Kreider JM; D'Silva NJ; Chakravarty S; Dugar S; Higgins LS; Protter AA; Medicherla S
J Pharmacol Exp Ther; 2007 Jan; 320(1):56-63. PubMed ID: 17041006
[TBL] [Abstract][Full Text] [Related]
2. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
Rogers JE; Li F; Coatney DD; Otremba J; Kriegl JM; Protter TA; Higgins LS; Medicherla S; Kirkwood KL
J Periodontol; 2007 Oct; 78(10):1992-8. PubMed ID: 18062121
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
[TBL] [Abstract][Full Text] [Related]
4. Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts.
Patil C; Rossa C; Kirkwood KL
Oral Microbiol Immunol; 2006 Dec; 21(6):392-8. PubMed ID: 17064398
[TBL] [Abstract][Full Text] [Related]
5. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats.
Gürkan A; Emingil G; Nizam N; Doğanavşargil B; Sezak M; Kütükçüler N; Atilla G
J Periodontol; 2009 Oct; 80(10):1655-64. PubMed ID: 19792856
[TBL] [Abstract][Full Text] [Related]
7. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis.
Medicherla S; Ma JY; Mangadu R; Jiang Y; Zhao JJ; Almirez R; Kerr I; Stebbins EG; O'Young G; Kapoun AM; Luedtke G; Chakravarty S; Dugar S; Genant HK; Protter AA
J Pharmacol Exp Ther; 2006 Jul; 318(1):132-41. PubMed ID: 16597712
[TBL] [Abstract][Full Text] [Related]
8. Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis.
Rogers JE; Li F; Coatney DD; Rossa C; Bronson P; Krieder JM; Giannobile WV; Kirkwood KL
J Periodontol; 2007 Mar; 78(3):550-8. PubMed ID: 17335380
[TBL] [Abstract][Full Text] [Related]
9. p38 Mitogen-activated protein kinase inhibition reduces inflammatory cytokines in a brain-dead transplant donor animal model.
Oto T; Calderone A; Li Z; Rosenfeldt FL; Pepe S
Heart Lung Circ; 2009 Dec; 18(6):393-400. PubMed ID: 19647484
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of reduction of albumin expression induced by lipopolysaccharide in rat hepatocytes.
Wang XY; Li WQ; Lu J; Li N; Li JS
Chin Med J (Engl); 2005 Oct; 118(20):1695-702. PubMed ID: 16313754
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
Oikawa A; Kobayashi M; Okamatsu Y; Shinki T; Kamijo R; Yamamoto M; Hasegawa K
J Periodontal Res; 2007 Aug; 42(4):367-76. PubMed ID: 17559635
[TBL] [Abstract][Full Text] [Related]
12. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.
Shoji T; Yoshida S; Mitsunari M; Miyake N; Tsukihara S; Iwabe T; Harada T; Terakawa N
J Reprod Immunol; 2007 Oct; 75(2):82-90. PubMed ID: 17617469
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
15. Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor.
Caverzasio J; Higgins L; Ammann P
J Bone Miner Res; 2008 Sep; 23(9):1389-97. PubMed ID: 18442314
[TBL] [Abstract][Full Text] [Related]
16. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
17. Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes.
Neuder LE; Keener JM; Eckert RE; Trujillo JC; Jones SL
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):192-9. PubMed ID: 19070370
[TBL] [Abstract][Full Text] [Related]
18. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
[TBL] [Abstract][Full Text] [Related]
19. Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Wurz RP; Pettus LH; Henkle B; Sherman L; Plant M; Miner K; McBride HJ; Wong LM; Saris CJ; Lee MR; Chmait S; Mohr C; Hsieh F; Tasker AS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1680-4. PubMed ID: 20138761
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.
Ou XM; Wang BD; Wen FQ; Feng YL; Huang XY; Xiao J
Chin Med J (Engl); 2008 Sep; 121(17):1680-7. PubMed ID: 19024099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
